Logo image of GRN.CA

GREENLANE RENEWABLES INC (GRN.CA) Stock Fundamental Analysis

TSX:GRN - Toronto Stock Exchange - CA3953321096 - Common Stock - Currency: CAD

0.1  0 (0%)

Fundamental Rating

4

Overall GRN gets a fundamental rating of 4 out of 10. We evaluated GRN against 207 industry peers in the Oil, Gas & Consumable Fuels industry. While GRN seems to be doing ok healthwise, there are quite some concerns on its profitability. GRN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year GRN has reported negative net income.
In the past year GRN had a positive cash flow from operations.
GRN had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: GRN reported negative operating cash flow in multiple years.
GRN.CA Yearly Net Income VS EBIT VS OCF VS FCFGRN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M

1.2 Ratios

With a Return On Assets value of -6.49%, GRN is not doing good in the industry: 60.87% of the companies in the same industry are doing better.
GRN has a Return On Equity (-12.48%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -6.49%
ROE -12.48%
ROIC N/A
ROA(3y)-21.71%
ROA(5y)-14.79%
ROE(3y)-44.99%
ROE(5y)-29.77%
ROIC(3y)N/A
ROIC(5y)N/A
GRN.CA Yearly ROA, ROE, ROICGRN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

GRN has a Gross Margin of 30.62%. This is comparable to the rest of the industry: GRN outperforms 49.76% of its industry peers.
In the last couple of years the Gross Margin of GRN has declined.
GRN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.62%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.55%
GM growth 5Y-3.64%
GRN.CA Yearly Profit, Operating, Gross MarginsGRN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

5

2. Health

2.1 Basic Checks

GRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GRN has been increased compared to 1 year ago.
The number of shares outstanding for GRN has been increased compared to 5 years ago.
The debt/assets ratio for GRN is higher compared to a year ago.
GRN.CA Yearly Shares OutstandingGRN.CA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
GRN.CA Yearly Total Debt VS Total AssetsGRN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of 0.24, we must say that GRN is in the distress zone and has some risk of bankruptcy.
GRN has a worse Altman-Z score (0.24) than 63.28% of its industry peers.
GRN has a debt to FCF ratio of 0.25. This is a very positive value and a sign of high solvency as it would only need 0.25 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.25, GRN belongs to the top of the industry, outperforming 93.72% of the companies in the same industry.
A Debt/Equity ratio of 0.07 indicates that GRN is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.07, GRN is doing good in the industry, outperforming 74.88% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 0.25
Altman-Z 0.24
ROIC/WACCN/A
WACC8.19%
GRN.CA Yearly LT Debt VS Equity VS FCFGRN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

A Current Ratio of 1.65 indicates that GRN should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.65, GRN is doing good in the industry, outperforming 79.71% of the companies in the same industry.
GRN has a Quick Ratio of 1.58. This is a normal value and indicates that GRN is financially healthy and should not expect problems in meeting its short term obligations.
GRN has a Quick ratio of 1.58. This is in the better half of the industry: GRN outperforms 78.26% of its industry peers.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.58
GRN.CA Yearly Current Assets VS Current LiabilitesGRN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

5

3. Growth

3.1 Past

GRN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 91.46%, which is quite impressive.
Looking at the last year, GRN shows a decrease in Revenue. The Revenue has decreased by -2.72% in the last year.
Measured over the past years, GRN shows a very strong growth in Revenue. The Revenue has been growing by 41.55% on average per year.
EPS 1Y (TTM)91.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-22.64%
Revenue 1Y (TTM)-2.72%
Revenue growth 3Y-2.17%
Revenue growth 5Y41.55%
Sales Q2Q%-61.35%

3.2 Future

GRN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 76.66% yearly.
GRN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.33% yearly.
EPS Next Y-75%
EPS Next 2Y169.21%
EPS Next 3Y118.21%
EPS Next 5Y76.66%
Revenue Next Year-36.54%
Revenue Next 2Y23.98%
Revenue Next 3Y11.49%
Revenue Next 5Y11.33%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
GRN.CA Yearly Revenue VS EstimatesGRN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 20M 40M 60M 80M
GRN.CA Yearly EPS VS EstimatesGRN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 -0.2 0.4 0.6

5

4. Valuation

4.1 Price/Earnings Ratio

GRN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
GRN is valuated cheaply with a Price/Forward Earnings ratio of 0.47.
Based on the Price/Forward Earnings ratio, GRN is valued cheaper than 100.00% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.76. GRN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 0.47
GRN.CA Price Earnings VS Forward Price EarningsGRN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

GRN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. GRN is cheaper than 99.03% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.94
EV/EBITDA N/A
GRN.CA Per share dataGRN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3

4.3 Compensation for Growth

A more expensive valuation may be justified as GRN's earnings are expected to grow with 118.21% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y169.21%
EPS Next 3Y118.21%

0

5. Dividend

5.1 Amount

No dividends for GRN!.
Industry RankSector Rank
Dividend Yield N/A

GREENLANE RENEWABLES INC

TSX:GRN (7/11/2025, 7:00:00 PM)

0.1

0 (0%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-15 2025-05-15
Earnings (Next)08-06 2025-08-06
Inst Owners2.87%
Inst Owner ChangeN/A
Ins Owners8.92%
Ins Owner ChangeN/A
Market Cap15.69M
Analysts45.71
Price Target0.2 (100%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.47
P/S 0.27
P/FCF 1.94
P/OCF 1.93
P/B 0.68
P/tB 1.25
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)0.21
Fwd EY212%
FCF(TTM)0.05
FCFY51.41%
OCF(TTM)0.05
OCFY51.71%
SpS0.37
BVpS0.15
TBVpS0.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.49%
ROE -12.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 30.62%
FCFM 13.71%
ROA(3y)-21.71%
ROA(5y)-14.79%
ROE(3y)-44.99%
ROE(5y)-29.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.55%
GM growth 5Y-3.64%
F-Score6
Asset Turnover1.33
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 0.25
Debt/EBITDA N/A
Cap/Depr 4.25%
Cap/Sales 0.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.65
Quick Ratio 1.58
Altman-Z 0.24
F-Score6
WACC8.19%
ROIC/WACCN/A
Cap/Depr(3y)12.44%
Cap/Depr(5y)10.92%
Cap/Sales(3y)0.41%
Cap/Sales(5y)0.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)91.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-22.64%
EPS Next Y-75%
EPS Next 2Y169.21%
EPS Next 3Y118.21%
EPS Next 5Y76.66%
Revenue 1Y (TTM)-2.72%
Revenue growth 3Y-2.17%
Revenue growth 5Y41.55%
Sales Q2Q%-61.35%
Revenue Next Year-36.54%
Revenue Next 2Y23.98%
Revenue Next 3Y11.49%
Revenue Next 5Y11.33%
EBIT growth 1Y59.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year44.35%
EBIT Next 3Y18.57%
EBIT Next 5Y16.66%
FCF growth 1Y307.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y339.38%
OCF growth 3YN/A
OCF growth 5YN/A